ClinicalTrials.gov
ClinicalTrials.gov Menu

BIOBANK Renal Transplantation University Hospitals Leuven

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01331668
Recruitment Status : Recruiting
First Posted : April 8, 2011
Last Update Posted : May 11, 2016
Sponsor:
Information provided by (Responsible Party):
Prof Dr Maarten Naesens, Universitaire Ziekenhuizen Leuven

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This study aims to maintain a prospective biobank of human samples obtained from donors and recipients of renal allografts, including biopsy tissue, peripheral blood samples and urine samples.

Condition or disease
Kidney Failure

Detailed Description:
Clinical data and bio-specimens are prospectively collected and stored for undefined future translational research projects.

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Estimated Enrollment : 5000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Biobank Renal Transplantation University Hospitals Leuven
Study Start Date : March 2004
Estimated Primary Completion Date : December 2099
Estimated Study Completion Date : December 2099

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
renal allograft donors and recipients
All de novo renal allograft recipients transplanted at the University Hospitals Leuven


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Renal allograft survival [ Time Frame: 50 years after transplantation ]

Biospecimen Retention:   Samples With DNA
Biopsy material (tissue, RNA, DNA) Peripheral blood samples (serum, plasma, RNA, DNA) Urine samples

Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All donors and recipients of a kidney transplant at the University Hospitals Leuven
Criteria

Inclusion Criteria:

  • renal transplant recipients/donors

Exclusion Criteria:

Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01331668


Contacts
Contact: Maarten Naesens, MD, PhD 32 16344580 maarten.naesens@uzleuven.be

Locations
Belgium
Department of Nephrology and Renal Transplantation - University Hospitals Leuven Recruiting
Leuven, BE, Belgium, 3000
Contact: Maarten Naesens, MD, PhD    32 16344580    maarten.naesens@uzleuven.be   
Principal Investigator: Maarten Naesens, MD, PhD         
Principal Investigator: Dirk Kuypers, MD, PhD         
Sponsors and Collaborators
Universitaire Ziekenhuizen Leuven
Investigators
Principal Investigator: Maarten Naesens, MD, PhD University Hospitals Leuven
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications of Results:

Other Publications:

Responsible Party: Prof Dr Maarten Naesens, Prof. Dr. Maarten Naesens, Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier: NCT01331668     History of Changes
Other Study ID Numbers: TRA-UZL-BIOBANK-001
First Posted: April 8, 2011    Key Record Dates
Last Update Posted: May 11, 2016
Last Verified: May 2016

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Diseases
Urologic Diseases